(Q44832660)

English

A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

James M Scheiman

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Byron Cryer

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Michael B Kimmey

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Richard I Rothstein

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dennis S Riff

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Michael M Wolfe

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

290-295

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of nonparametric methods for the analysis of crossover studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric adaptation. Studies in humans during continuous aspirin administration

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900057-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1542-3565(04)00057-6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44832660&oldid=2048834741"